Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03261700 · ClinicalTrials.gov registry record · NA
Recovering From Intimate Partner Violence Through Strengths and Empowerment (RISE)
A NA study of Self Efficacy and Intimate Partner Violence, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT03261700 is a NA study of Self Efficacy and Intimate Partner Violence that has completed, run by VA Office of Research and Development. The registered enrollment target is 60 participants, below the 152-participant average among 30 other Self Efficacy trials with a reported enrollment target (61% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03261700, a NA study of Self Efficacy and Intimate Partner Violence, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
Intimate partner violence (IPV) is a major health concern for women Veterans. IPV is associated with numerous physical and mental health conditions. VHA is implementing IPV screening programs to identify female patients who experience past-year IPV. Despite strong evidence that screening increases detection of IPV, less is established about how to intervene following IPV disclosure in health care settings, in order to improve health outcomes. Existing healthcare-based interventions result in minimal effects on health and well-being, likely because they are too brief and generic. In response, the PI has developed Recovering from IPV through Strengths and Empowerment (RISE), based on the IPV-related health care needs and preferences of women Veterans. RISE is designed to be delivered in primary care and is an individualized, variable-length, modular-based intervention that addresses * safety planning; * education on the health effects of IPV and warning signs; * increasing coping skills and self-care; * enhancing social support; * making difficult decisions; and * connecting with resources. This study is aimed at refining and evaluating RISE for use with female VA patients who have experienced past-year IPV. This brief counseling intervention is intended to be administered in conjunction with primary care, as this is a frequent point of healthcare contact for women Veterans and where disclosure of IPV is most prevalent.
Conditions Studied
Interventions
- BEHAVIORAL RISE
- OTHER Information and referral condition
Study Locations (1)
Massachusetts
- VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2018-10-22 |
| Est. Completion | 2020-11-23 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03261700
The ClinicalTrials.gov registry entry for NCT03261700 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 152-participant average among 30 other Self Efficacy trials with a reported enrollment target (61% lower). The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Self Efficacy appearing as the primary indexed condition, and to 2 interventions - of which RISE is the first listed.
NCT03261700 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT03261700 about?
NCT03261700 is a clinical study titled "Recovering From Intimate Partner Violence Through Strengths and Empowerment (RISE)". Intimate partner violence (IPV) is a major health concern for women Veterans. IPV is associated with numerous physical and mental health conditions. VHA is implementing IPV screening programs to identify female patients who experience past-year IPV. Despite strong evidence that screening increases d...
What is the current status of trial NCT03261700?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2018-10-22. Estimated completion is 2020-11-23.
What conditions does trial NCT03261700 study?
This clinical trial studies the following conditions: Self Efficacy, Intimate Partner Violence.
What interventions are being tested in trial NCT03261700?
The interventions under investigation include: RISE (BEHAVIORAL), Information and referral condition (OTHER).
Who is sponsoring clinical trial NCT03261700?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03261700 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Self Efficacy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
An Informational and Supportive Care Intervention for Patients With Locally Advanced Rectal Cancer
RECRUITING · NA
-
The Fit With Us Study
RECRUITING · NA
-
Health Care Transition Readiness Short-Form Video Intervention
RECRUITING · NA
-
Text-messaging Intervention to Support Parents After Their Child's Psychiatric Emergency
RECRUITING · NA
-
Learning Skills Together Family Caregiver Complex Intervention
RECRUITING · NA
-
Palliative Care Education in Assisted Living for Dementia Care Providers (PCEAL-DCP)
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.